A Prospective Clinical Study to Assess the Hemodynamic Changes and Safety of 0.5% Levobupivacaine Hyperbaric for Spinal Anaesthesia in Adult Patients.
Аннотация
BACKGROUND
This study evaluates the hemodynamic effects safety and block characteristics of 0.5% hyperbaric levobupivacaine for spinal anesthesia in adults undergoing infraumbilical surgeries.
MATERIALS AND
METHODS
A prospective study was conducted with 75 ASA I-II patients aged 18-65 years. Each patient received 3.5 ml of 0.5% hyperbaric levobupivacaine at the L2/L3 or L3/L4 level. Hemodynamic parameters were monitored, and sensory and motor block characteristics were assessed. Postoperative pain was recorded using the Visual Analog Scale (VAS).
RESULTS
Hemodynamic stability was observed, with 2.66% of patients experiencing hypotension and none reporting bradycardia. Sensory block onset averaged 2.37 ± 0.70 min, lasting 201.35 ± 16.50 min. Motor block onset was 4.57 ± 0.54 min, lasting 171.27 ± 7.57 min. Severe pain (VAS ≥4) occurred in 62.6% at 4 hours and 38.6% at 8 hours.
CONCLUSIONS
Hyperbaric 0.5% levobupivacaine provides effective anesthesia with stable hemodynamics. However, shorter analgesia duration suggests a need for additional postoperative pain management.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.